Synbio International Inc. (OTC: SYIN) ("Synbio" or the "Company"), a medical technology company focused on clinically ...
Poster presentation highlighted promising pharmacology and behavioral results on lead candidate, TN-001, in preclinical studies. TN-001 is under development for both major depressive disorder (MDD) ...
Valerie Zeko emerged from 28 years of debilitating depression after participating in a groundbreaking trial at Stanford, ...
DONGGUAN, GUANGDONG, CHINA, January 13, 2026 /EINPresswire.com/ -- As healthcare increasingly shifts towards at-home ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback